基础医学与临床 ›› 2008, Vol. 28 ›› Issue (12): 1332-1335.

• 短篇综述 • 上一篇    下一篇

TLR4及内源性配体对缺血-再灌注损伤的作用

陈雪峰 何桂珍 董良广   

  1. 中国医学科学院 中国协和医科大学 北京协和医院 中国医学科学院 中国协和医科大学 北京协和医院
  • 收稿日期:2008-05-14 修回日期:2008-08-06 出版日期:2008-12-25 发布日期:2008-12-25
  • 通讯作者: 何桂珍

Effect of Toll Like Receptor 4 and its endogenous ligands in ischemia-reperfusion injury

Xue-feng CHEN, Gui-zhen HE, Liang-guang DONG   

  1. PUMC Hospitol ,CAMS&PUMC PUMC Hospitol ,CAMS&PUMC
  • Received:2008-05-14 Revised:2008-08-06 Online:2008-12-25 Published:2008-12-25
  • Contact: Gui-zhen HE,

摘要: Toll样受体4(TLR4)在内源性配体参与下介导缺血再灌注损伤,两者的结合对组织损伤和固有免疫应答起重要作用。肝、肾、肺、脑等发生缺血再灌注损伤早期,细胞释放各种内源性配体,被TLR4 识别并结合。Toll样受体4与内源性配体(如HMGB1)的结合可能是缺血再灌注损伤中最主要的炎症应答的触发器,并引起一系列导致炎症和免疫应答的级联反应。阻断两者的结合可能对各种缺血-再灌注损伤引起的炎症反应和细胞损伤有保护作用。

Abstract: TLR4 mediates I/R injury involving endogenous ligands. Interaction of TLR4 with endogenous ligands provides a critical link between tissue damage and activation of the innate immune response.In the early onset of liver, kidney, heart,or lung I/R injury,endogenous ligands are secreated from several kinds of cells , and they are recognized by TLR4. Interaction of TLR4 with endogenous ligands,such as HMGB1 ,seems to be the most important trigger of inflammation and initiates signaling cascades leading to inflammatory and immune responses.Blocking the interaction of TLR4 with endogenous ligands may be useful in clinical settings associated with inflammation and cellular necrosis caused by ischemic insults.